Hypoxia-responsive ionizable liposome delivery siRNA for glioma therapyHongmei Liu, Rutong Yu|International Journal of Nanomedicine|2017Cited by 95
CRM1/XPO1 is associated with clinical outcome in glioma and represents a therapeutic target by perturbing multiple core pathwaysXuejiao Liu, Rutong Yu|Journal of Hematology & Oncology|2016Cited by 80
<p>Combined Delivery of Temozolomide and siPLK1 Using Targeted Nanoparticles to Enhance Temozolomide Sensitivity in Glioma</p>Hui Shi, Rutong Yu|International Journal of Nanomedicine|2020Cited by 56
Overexpression of RASD1 inhibits glioma cell migration/invasion and inactivates the AKT/mTOR signaling pathwayShangfeng Gao, Rutong Yu|Scientific Reports|2017Cited by 36
CacyBP/SIP protein is important for the proliferation of human glioma cellsHengliang Shi, Rutong Yu|IUBMB Life|2014Cited by 35